Opportunity Information: Apply for RFA CA 15 013
Apply for RFA CA 15 013
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Provocative Questions in Cancer with an Underlying HIV Infection (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.395 Cancer Treatment Research.
- This funding opportunity was created on May 14, 2015 and posted on May 14, 2015.
- Applicants must submit their applications by Aug 18, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $4,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education State governments Others (see text field entitled Additional Information on Eligibility for clarification) County governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Provocative Questions in Cancer with an Underlying HIV Infection (R21)" (Funding Opportunity Number RFA-CA-15-013) is a National Institutes of Health (NIH) funding announcement aimed at pushing forward research on cancers that occur in people living with HIV or with AIDS. The central goal is to improve scientific understanding of how cancer risk emerges, how these malignancies develop and progress over time, how they can be detected and diagnosed more effectively, and how they can be treated in the context of HIV-related immune dysfunction and clinical complexity. Instead of broadly funding any HIV-and-cancer topic, the announcement is built around a set of targeted "Provocative Questions" (PQs). These questions are designed to spotlight important but under-studied problems, contradictions, and gaps in knowledge within AIDS-related cancer research, essentially nudging investigators to tackle issues that may be scientifically challenging, conceptually overlooked, or difficult to study with traditional approaches.
This is an R21 mechanism, meaning it supports exploratory and developmental research projects. In practice, R21 awards are often used to seed early-stage, high-impact ideas, pilot studies, and novel directions that can generate key data or proof-of-concept results. The opportunity emphasizes research that is explicitly aligned with one of the proposed Provocative Questions rather than simply being generally relevant to HIV and cancer. The PQ framing signals that reviewers will be looking for applications that directly address the specific unanswered questions highlighted by the National Cancer Institute (NCI), rather than incremental extensions of existing work. It also indicates that the FOA is not intended to represent the entire NCI HIV/AIDS cancer research portfolio; it is a deliberately selective call intended to draw attention to areas that have not received enough focused investigation.
Administratively, this opportunity falls under the NIH and is categorized as discretionary grant funding within the health and education activity space. It is associated with CFDA numbers 93.393 (Cancer Cause and Prevention Research) and 93.395 (Cancer Treatment Research). The announcement states there is no cost sharing or matching requirement, so applicants are not expected to provide matching funds as a condition of receiving an award. The estimated total funding level listed is $4,000,000, and the award ceiling is $200,000, which reflects the maximum direct cost level indicated in the summary information provided.
Eligibility is broad and includes many types of organizations capable of conducting biomedical and behavioral research. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including both 501(c)(3) and non-501(c)(3) nonprofits), for-profit organizations (including small businesses and other for-profits), state and county governments, and other entities as permitted under NIH rules. The eligibility details also explicitly include a wide range of institutions and organizational categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). Importantly, the FOA also allows non-domestic (non-U.S.) entities (foreign organizations), regional organizations, eligible federal agencies, and U.S. territories or possessions, which expands the potential applicant pool to groups that can contribute international cohorts, diverse populations, and cross-border expertise relevant to HIV-associated malignancies.
The timeline information in the provided source indicates the FOA was posted and created on May 14, 2015. The original and current closing date listed is August 18, 2016, and the archive date is September 18, 2016, meaning it was a time-limited opportunity that has since been archived. For applicants or researchers looking to understand the full scope of the Provocative Questions and the required application elements, the official announcement was made available through NIH at the provided link (http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-013.html). For technical access issues, the contact route listed is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Overall, the opportunity can be summarized as a targeted, question-driven NIH/NCI R21 call meant to catalyze creative, hypothesis-generating, and potentially high-yield research focused on cancers in people with HIV/AIDS, especially in areas where the science presents unresolved puzzles or has not kept pace with clinical need.
FAQs: Provocative Questions in Cancer with an Underlying HIV Infection (R21) - RFA-CA-15-013
What is the title of this grant opportunity?
The funding opportunity is titled "Provocative Questions in Cancer with an Underlying HIV Infection (R21)."
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is RFA-CA-15-013.
Which agency is offering this opportunity?
This opportunity is offered through the National Institutes of Health (NIH), and it is focused within the National Cancer Institute (NCI) research area related to HIV-associated malignancies.
What is the main purpose of this FOA?
The purpose is to advance research on cancers that occur in people living with HIV or with AIDS, with the goal of improving scientific understanding of cancer risk, development and progression, detection and diagnosis, and treatment in the context of HIV-related immune dysfunction and clinical complexity.
What types of research topics does this FOA prioritize?
This FOA prioritizes projects that are explicitly aligned with one of the targeted "Provocative Questions" (PQs) identified for AIDS-related cancer research, rather than projects that are only broadly related to HIV and cancer.
What are "Provocative Questions" (PQs) in this announcement?
PQs are targeted research questions designed to highlight important but under-studied problems, contradictions, and gaps in knowledge in AIDS-related cancer research. The FOA is structured around these questions to encourage investigators to pursue challenging or overlooked issues.
Does an application need to directly address a Provocative Question?
Yes. The opportunity emphasizes research that is explicitly aligned with one of the proposed Provocative Questions, and indicates that reviewers will be looking for applications that directly address the specific unanswered questions highlighted by NCI.
What grant mechanism is used for this opportunity?
This is an R21 mechanism.
What does the R21 mechanism support?
R21 awards support exploratory and developmental research projects. They are commonly used for early-stage, high-impact ideas, pilot studies, and novel directions that can generate key data or proof-of-concept results.
Is this FOA meant to cover the entire NIH/NCI HIV-and-cancer research portfolio?
No. The announcement indicates it is not intended to represent the entire NCI HIV/AIDS cancer research portfolio. It is a selective, question-driven call intended to draw attention to areas needing more focused investigation.
What is the estimated total funding available?
The estimated total funding level listed is $4,000,000.
What is the award ceiling for this opportunity?
The award ceiling is $200,000 (as reflected by the maximum direct cost level indicated in the summary information provided).
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
How is this opportunity categorized?
It is described as discretionary grant funding within the health and education activity space under NIH.
Which CFDA numbers are associated with this FOA?
The FOA is associated with CFDA 93.393 (Cancer Cause and Prevention Research) and 93.395 (Cancer Treatment Research).
Who is eligible to apply?
Eligibility is broad and includes organizations capable of conducting biomedical and behavioral research. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (both 501(c)(3) and non-501(c)(3)), for-profit organizations (including small businesses and other for-profits), state and county governments, and other entities as permitted under NIH rules.
Are minority-serving institutions explicitly included as eligible?
Yes. The eligibility details explicitly include institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
Are non-U.S. (foreign) organizations eligible to apply?
Yes. The FOA allows non-domestic (non-U.S.) entities (foreign organizations), as well as regional organizations.
Are U.S. territories and possessions eligible?
Yes. The eligibility details include U.S. territories or possessions.
Are federal agencies eligible to apply?
Yes. The FOA allows eligible federal agencies.
When was this FOA posted?
The FOA was posted and created on May 14, 2015.
What was the closing date for applications?
The original and current closing date listed is August 18, 2016.
Is this funding opportunity still open?
No. The archive date is September 18, 2016, indicating it was time-limited and has since been archived.
Where can applicants find the official FOA and full details (including the Provocative Questions)?
The official announcement is available through NIH at: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-013.html
Who should be contacted for technical access issues related to the FOA webpage?
The listed contact route for technical access issues is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
What is the overall emphasis of this opportunity in plain terms?
It is a targeted NIH/NCI R21 call meant to catalyze creative, hypothesis-generating, and potentially high-yield research focused on cancers in people with HIV/AIDS, especially in areas where key scientific questions remain unresolved or under-studied.
Browse more opportunities from the same category: Education Health
Next opportunity: Provocative Questions (PQ) Initiative Cancer with an Underlying HIV Infection (R01)
Previous opportunity: BJA FY 15 Technology Innovation for Public Safety (TIPS)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 15 013
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 15 013) also looked into and applied for these:
| Funding Opportunity |
|---|
| Provocative Questions (PQ) Initiative Cancer with an Underlying HIV Infection (R01) Apply for RFA CA 15 012 Funding Number: RFA CA 15 012 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Clinical and Translational Science Award (CTSA) Network Recruitment Innovation Centers (RICs)(U24) Apply for RFA TR 15 004 Funding Number: RFA TR 15 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Assay Validation For High Quality Markers For NCI Supported Clinical Trials (Admin Supp) Apply for PA 15 264 Funding Number: PA 15 264 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Martin Delaney Collaboratories for HIV Cure Research (UM1) Apply for RFA AI 15 029 Funding Number: RFA AI 15 029 Agency: National Institutes of Health Category: Education Health Funding Amount: $3,500,000 |
| Oncology Co Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24) Apply for PAR 15 266 Funding Number: PAR 15 266 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Fast Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3) Apply for PAR 15 267 Funding Number: PAR 15 267 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Harnessing Genome Editing Technologies to Functionally Validate Genetic Variants in Substance Use Disorders (R21/R33) Apply for RFA DA 16 004 Funding Number: RFA DA 16 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools and Services for Designing Methodologically Rigorous Animal Studies (R41/R42) Apply for RFA DA 16 002 Funding Number: RFA DA 16 002 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools and Services for Designing Methodologically Rigorous Animal Studies (R43/R44) Apply for RFA DA 16 003 Funding Number: RFA DA 16 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Career Development Program in Emergency Care Research (K12) Apply for RFA HL 16 019 Funding Number: RFA HL 16 019 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Harnessing Big Data to Halt HIV (R01) Apply for PA 15 273 Funding Number: PA 15 273 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Smoking Cessation within the Context of Lung Cancer Screening (R01) Apply for RFA CA 15 011 Funding Number: RFA CA 15 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Ethical Issues in Research on HIV/AIDS and its Co Morbidities (R01) Apply for PAR 15 274 Funding Number: PAR 15 274 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Ethical Issues in Research on HIV/AIDS and its Co Morbidities (R21) Apply for PAR 15 275 Funding Number: PAR 15 275 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Turkey US Collaborative Program for Affordable Medical Technologies (R01) Apply for PAR 15 276 Funding Number: PAR 15 276 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Multidisciplinary Studies of HIV/AIDS and Aging (R01) Apply for PAR 15 280 Funding Number: PAR 15 280 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Multidisciplinary Studies of HIV/AIDS and Aging (R03) Apply for PAR 15 281 Funding Number: PAR 15 281 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Multidisciplinary Studies of HIV/AIDS and Aging (R21) Apply for PAR 15 282 Funding Number: PAR 15 282 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Extracellular Vesicles and Substance Abuse (R21) Apply for PAR 15 284 Funding Number: PAR 15 284 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Extracellular Vesicles and Substance Abuse (R01) Apply for PAR 15 283 Funding Number: PAR 15 283 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 15 013", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
